We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-8.83%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$3.57B
AUM Growth
-$614M
(-15%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
1.44%
Top 10 Holdings %
Top 10 Hldgs %
48.82%
Holding
78
New
14
Increased
15
Reduced
33
Closed
9
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
+$73M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$72.6M |
| 3 |
ONEM
1Life Healthcare
ONEM
|
+$68.5M |
| 4 |
Merck
MRK
|
+$64.9M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$53.9M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$116M |
| 2 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
+$109M |
| 3 |
Boston Scientific
BSX
|
+$73.8M |
| 4 |
Centene
CNC
|
+$44.2M |
| 5 |
HCA Healthcare
HCA
|
+$42.2M |
Sector Composition
| 1 | Healthcare | 97.84% |
| 2 | Industrials | 0.87% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$349M
| $249M | 6.98% |
11,216,809
| – | – |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $233M | 6.52% |
25,181,500
-28,464
| -0.1% | -$271K |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $211M | 5.91% |
5,116,263
+406,765
| +9% | +$22.6M |
|
4
Biogen
BIIB
$29.1B
| $186M | 5.23% |
589,300
+131,800
| +29% | +$40M |
|
|
IGMS
5
DELISTED
IGM Biosciences
IGMS
| $177M | 4.95% |
3,144,000
| – | – |
|
6
argenx
ARGX
$54B
| $143M | 4% |
1,082,070
-71,162
| -6% | -$10.4M |
|
|
MNTA
7
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $141M | 3.95% |
5,175,008
+1,937,308
| +60% | +$53.9M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $136M | 3.81% |
8,768,475
+22,442
| +0.3% | +$482K |
|
|
PRNB
9
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $134M | 3.76% |
2,261,088
-461,300
| -17% | -$26.9M |
|
|
ALLK
10
DELISTED
Allakos
ALLK
| $132M | 3.71% |
2,976,928
-56,598
| -2% | -$3.87M |
|
11
uniQure
QURE
$2.82B
| $132M | 3.69% |
2,773,525
+220,200
| +9% | +$12.7M |
|
12
Aprea Therapeutics
APRE
$8.64M
| $78.9M | 2.21% |
113,436
| – | – |
|
13
Regenxbio
RGNX
$634M
| $75.7M | 2.12% |
2,338,466
-169,920
| -7% | -$7.08M |
|
|
SGEN
14
DELISTED
Seagen Inc. Common Stock
SGEN
| $75.7M | 2.12% |
+655,700
| New | +$72.6M |
|
|
NVRO
15
DELISTED
NEVRO CORP.
NVRO
| $70.6M | 1.98% |
706,426
-232,738
| -25% | -$28M |
|
|
16
Merck
MRK
$305B
| $60.7M | 1.7% |
+826,348
| New | +$64.9M |
|
|
17
Beam Therapeutics
BEAM
$3.17B
| $60.5M | 1.7% |
+3,359,258
| New | +$73M |
|
18
UnitedHealth
UNH
$380B
| $60.1M | 1.69% |
241,100
+38,000
| +19% | +$10.5M |
|
|
IMGN
19
DELISTED
Immunogen Inc
IMGN
| $57.1M | 1.6% |
16,733,879
+2,093,919
| +14% | +$9.15M |
|
20
Tandem Diabetes Care
TNDM
$1.05B
| $56.7M | 1.59% |
881,266
-290,966
| -25% | -$20.4M |
|
|
ONEM
21
DELISTED
1Life Healthcare
ONEM
| $56.7M | 1.59% |
+3,123,384
| New | +$68.5M |
|
22
Novartis
NVS
$288B
| $53.9M | 1.51% |
653,600
+80,500
| +14% | +$7.18M |
|
23
Cigna
CI
$78.8B
| $53.3M | 1.49% |
300,600
+153,100
| +104% | +$29.7M |
|
24
Stoke Therapeutics
STOK
$1.86B
| $49.6M | 1.39% |
2,165,938
+1,145,160
| +112% | +$28.3M |
|
|
25
Centene
CNC
$32.9B
| $49M | 1.37% |
824,090
-728,508
| -47% | -$44.2M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO